Kiro

Sections Clinical Biology
Technologies Artificial Intelligence
Funding π°
Total β¬17M
Key people π§βπ€βπ§
- Alexandre Guenoun - Founder & CEO
- Francois Le Vu - COO
- Stan Kocken - CTO
- GaΓ«l Saintenoy - Chief Medical Officer
Highlights β
- Report generation in seconds: Medically validated, Kiro can help interpret data from a broad range of lab tests and generate a report within seconds, enabling faster and more efficient patient care and empowering clinicians worldwide to better deliver their expertise.
- Strong product usage: As of March 2023, Kiro had more than 150,000 monthly active users.
- Expansion plans: On the heels of its Series A round of funding, the company said it plans to expand commercial operations in Europe and prepare entry into the US market. π
Awards & Recognitions π
- 2020 Investissement D'Avenir
- 2020 Netva Deep Tech North America
- 2019 Concours National De L'Innovation i-Lab
- 2019 Bpifrance Excellence
Quotes π¬
“
Kiro has the potential to combine laboratory tests with machine and deep learning algorithms to transform medical biology into a tool that empowers physicians and patients alike. We look forward to working with Alex and the team to revolutionize precision care: getting the right treatment for the right patient at the right time, but also in the right format - one that really talks to the patients themselves and makes them part of the journey.
— Edward Kliphuis, Partner at Sofinnova Partners π
Last update: May 9, 2023
Disclaimer: We can not guarantee that the information on this page is 100% correct. more